Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Herpes Remains Latent by Producing Self-inhibitory MicroRNA

By Biotechdaily staff writers
Posted on 15 Jul 2008
Molecular virologists have identified the mechanism used by the herpes simplex virus 1 (HSV1) to remain alive but latent in nerve cells until stimulated to renewed activity by excessive sunlight, fever, or other stresses.

During its latent phase, the virus does not replicate and practically the only molecular product that is being made is a type of RNA called latency-associated transcript RNA or LAT RNA. More...
While in the latent state the virus is not susceptible to antiviral treatment.
Writing in the July 2, 2008, online edition of the journal Nature, senior author Dr. Bryan Cullen, professor of molecular genetics and microbiology from Duke University (Durham, NC, USA), said, "It has always been a mystery what this product, LAT RNA, does. Usually viral RNAs exist to make proteins that are of use to the virus, but this LAT RNA is extremely unstable and does not make any proteins.”

Results presented in this study revealed that LAT functioned as a primary microRNA (miRNA) precursor that encoded four distinct miRNAs in HSV-1 infected cells. The investigators showed that one of the miRNAs, miR-H2-3p, was able to reduce expression of ICP0 protein--a viral immediate-early transcriptional activator that is important for productive HSV-1 replication--but did not significantly affect ICP0 messenger RNA levels. When faced with stress, the amount of ICP0 mRNA exceeded the amount of inhibitory miRNA, and the virus was stimulated to begin replication.

"Inactive virus is completely untouchable by any treatment we have. Unless you activate the virus, you cannot kill it,” said Dr. Cullen. "Once the virus is active, a patient would then take acyclovir, a drug that effectively kills replicating HSV1. In principle, you could activate and then kill all the virus in a patient. This would completely cure a person, and you would never get another cold sore.”


Related Links:
Duke University

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.